Reporting owner · Q3 2026 · CIK 2036989

Bliss Kelly: insider trades.

Bliss Kelly reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($93K), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
3
Companies
1
Name as filed
Bliss Kelly

Companies

CompanyRelationshipTransactions
Teladoc Health, Inc. (TDOC)Officer · President, U.S. Group Health6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-02Teladoc Health, Inc.S7,357$6.392,832Form 4
2026-09-01Teladoc Health, Inc.M1,300—100,189Form 4
2026-09-01Teladoc Health, Inc.M9,152—98,889Form 4
2026-09-01Teladoc Health, Inc.M4,859—89,737Form 4
2026-07-06Teladoc Health, Inc.S2,500$9.584,878Form 4
2026-07-01Teladoc Health, Inc.S2,500$987,378Form 4

Questions

What stock did Bliss Kelly buy or sell?

Bliss Kelly reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($93K), across 1 company.

Is Bliss Kelly the same person as other filers with this name?

This page covers SEC CIK 2036989 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/bliss-kelly-2036989.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.